These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 28483286
1. [Acute tubulo-interstitial nephritis due to RIVAROXABAN (XARELTO)]. Dantec A, Virot JS, Filancia A, Angonin R, Nefti H. Presse Med; 2017 May; 46(5):541-542. PubMed ID: 28483286 [No Abstract] [Full Text] [Related]
2. [New oral anticoagulants in patients with atrial fibrillation in a urban health center]. Rodríguez Pérez L, Capilla Lozano F, Gallego Fuentes R, Buitrago F. Med Clin (Barc); 2016 Mar 18; 146(6):280-1. PubMed ID: 26343157 [No Abstract] [Full Text] [Related]
3. A case of rivaroxaban-associated acute tubulointerstitial nephritis. Monahan RC, Suttorp MM, Gabreëls BATF. Neth J Med; 2017 May 18; 75(4):169-171. PubMed ID: 28522776 [Abstract] [Full Text] [Related]
4. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study. Maura G, Blotière PO, Bouillon K, Billionnet C, Ricordeau P, Alla F, Zureik M. Circulation; 2015 Sep 29; 132(13):1252-60. PubMed ID: 26199338 [Abstract] [Full Text] [Related]
5. Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke. Ritzenthaler T, Derex L, Davenas C, Bnouhanna W, Farghali A, Mechtouff L, Cho TH, Nighoghossian N. Rev Neurol (Paris); 2015 Sep 29; 171(8-9):613-5. PubMed ID: 25857461 [Abstract] [Full Text] [Related]
6. Rivaroxaban-Induced Acute Interstitial Nephritis: A Case Report. Zafar F, Iqbal AM, Mubarik A, Rojas M, Muddassir S. Am J Case Rep; 2019 Nov 21; 20():1719-1722. PubMed ID: 31748498 [Abstract] [Full Text] [Related]
7. Rivaroxaban-induced hemorrhagic pericardial tamponade in end-stage renal disease. Rapista N, Sarkar S, Chaudhary R. J Thromb Thrombolysis; 2020 Nov 21; 50(4):982-983. PubMed ID: 32495012 [No Abstract] [Full Text] [Related]
8. [Good efficacy and safety profile in clinical practice]. MMW Fortschr Med; 2015 Nov 19; 157(20):66-7. PubMed ID: 26977521 [No Abstract] [Full Text] [Related]
9. [Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation]. Saliba L, Mondoly P, Duparc A, Bura-Rivière A, Maury P, Calmels V, Sallerin B, Pathak A, Montastruc JL, Bagheri H. Therapie; 2015 Nov 19; 70(6):485-92. PubMed ID: 26223162 [Abstract] [Full Text] [Related]
15. Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study. Gioia LC, Kate M, Sivakumar L, Hussain D, Kalashyan H, Buck B, Bussiere M, Jeerakathil T, Shuaib A, Emery D, Butcher K. Stroke; 2016 Jul 19; 47(7):1917-9. PubMed ID: 27222524 [Abstract] [Full Text] [Related]
18. Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy. Sholzberg M, Xu Y. JAMA; 2018 Oct 09; 320(14):1485-1486. PubMed ID: 30242329 [No Abstract] [Full Text] [Related]